Predicting Risk for Post-polypectomy Colorectal Cancer
Key facts
- Who runs it
- Kaiser Permanente
- Where
- Oakland, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Sept 2022
- Ended
- 31 Dec 2023
- Type of study
- Interventional
- Treatments tested
- Logistic regression risk model
- Record updated
- 28 February 2023
- Why it stopped
- Alternative method of implementation, study not needed
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients are on the current colonoscopy pending list; excluding those who were fecal immunochemical test-positive, screening colonoscopies, had a colonoscopy in last 12 months or on a voluntary "pause" list
- Hereditary colorectal cancer syndrome (e.g. Lynch syndrome)
- Diagnostic, fecal immunochemical test -positive, or screening indication for colonoscopy
Where in United States
- Kaiser Permanente Northern California, Division of ResearchOakland, United States
About the trial
What the trial wants to find out
This originated as an observational study of Kaiser Permanente Northern California (KPNC) patients with a history of adenoma diagnosed by colonoscopy who received a subsequent surveillance colonoscopy between 2014 and 2019. The original goal of the study was to develop a risk prediction model that would help identify patients at highest risk for a diagnosis of advanced neoplasia (colorectal cancer and/or advanced adenoma) at or within 6 months following their surveillance colonoscopy. Candidate predictors of interest included patient demographics, medical history, and details related to the index colonoscopy. The investigators are now at the implementation stage and applying the risk prediction model to patients awaiting surveillance colonoscopy at select KPNC service areas to help identify those at highest risk for colorectal cancer based on their risk scores.
The group in the trial
- Use of risk prediction scoresTreatment being tested
The prediction model is being used to identify patients who are at highest risk for colorectal cancer based on their risk scores.
Treatment: Logistic regression risk model
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 28 February 2023